1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Sydnee Gatewood
Sydnee Gatewood
Articles (649) 

Steven Cohen Takes Stake in Biotech Company Agenus

Guru expands position in health care space

Point72 Asset Management leader Steven Cohen (Trades, Portfolio) disclosed this week he established a 6.13% stake in Agenus Inc. (NASDAQ:AGEN) on Feb. 21.

According to GuruFocus real-time picks, Cohen invested in 6.14 million shares of the Lexington, Massachusetts-based biotechnology company for an average price of $4.80 per share, giving it 0.13% portfolio space. He previously closed a position in the stock in first-quarter 2017.

6ab4af035d3317981a745babaf0d97af.png

In its third-quarter earnings report on Nov. 7, Agenus, which develops immuno-oncology drugs, posted a net loss of 88 cents per share on $3.36 million in revenue. It is scheduled to report fourth-quarter and full-year 2017 earnings on Thursday.

59580793.png

Agenus’ financial strength was rated 2 out of 10 by GuruFocus as it has poor earnings quality and its Altman Z-Score of -9.16 suggests it is under financial stress. While its operating margin is expanding, the company’s profitability and growth was rated 3 of 10 because it has a low Piotroski F-Score of 2 and a one-star business predictability rating (out of five).

The company has a market cap of $600.62 million; its shares were trading around $6, up 2.75%, on Wednesday with a price-sales ratio of 13.56. GuruFocus estimates the stock lost 14% in 2017. Year to date, it has gained 64%.

With his purchase, Cohen became the company’s largest guru shareholder. Ken Fisher (Trades, Portfolio) and Robert Bruce (Trades, Portfolio) also own the stock.

The guru, whose former hedge fund, SAC Capital Investors, was investigated for insider trading in 2012, now runs the $22.4 billion portfolio of Point72, which is a family asset manager based in Stamford, Connecticut.

With the goal of achieving superior risk-adjusted returns, Cohen’s current portfolio of 845 holdings is largely composed of stocks in the consumer cyclical and health care sectors. His largest health care positions are Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), Mylan NV(NASDAQ:MYL), Medtronic PLC (NYSE:MDT), Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) and Abbott Laboratories (NYSE:ABT).

Disclosure: No positions.

About the author:

Sydnee Gatewood
I am an editorial assistant at GuruFocus. I have a BA in journalism and a MA in mass communications from Texas Tech University. I have lived in Texas most of my life, but also have roots in New Mexico and Colorado. Follow me on Twitter! @gurusydneerg

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by Sydnee Gatewood


User Generated Screeners


andreahimmelretail
salvatore34200ma
kislevamnontrial good pio desc 10
emwebeCheapBlueChips
brandonyendreyEV/EBITDA
timjaegerPeter lynch screen
mjspencer1st%20look%20here%20for%20yiel
mjspencerhealthcare growth no debt
bdagrosaLong Stocks
HonteCapitalHDFF2019
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK